These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 17302610

  • 21. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples.
    Carrascosa JM, Tapia G, Bielsa I, Fuente MJ, Ferrandiz C.
    J Cutan Pathol; 2007 Oct; 34(10):769-76. PubMed ID: 17880582
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V, Gottlieb AB.
    J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC.
    J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M, Predd H, Underwood R, Cook P.
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [Abstract] [Full Text] [Related]

  • 30. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
    Markham T, Mathews C, Rogers S, Mullan R, Bresnihan B, Fitzgerald O, Veale DJ, Fearon U.
    Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis.
    Chang SL, Hu S, Hung SI, Huang YL, Hsiao WC, Chung WH.
    Arch Dermatol Res; 2010 Sep; 302(7):525-9. PubMed ID: 20336306
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
    Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC.
    J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
    [Abstract] [Full Text] [Related]

  • 37. Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.
    Jean J, Soucy J, Pouliot R.
    Tissue Eng Part A; 2011 Jul; 17(13-14):1859-68. PubMed ID: 21417679
    [Abstract] [Full Text] [Related]

  • 38. Examination of Bcl-2, Bcl-X and bax protein expression in psoriasis.
    Koçak M, Bozdogan O, Erkek E, Atasoy P, Birol A.
    Int J Dermatol; 2003 Oct; 42(10):789-93. PubMed ID: 14521691
    [Abstract] [Full Text] [Related]

  • 39. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes.
    Li X, Fan X, Zhang K, Yin G, Liu Y.
    Eur J Dermatol; 2007 Oct; 17(5):392-6. PubMed ID: 17673382
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.